Form 4 holding
Director, 10%+ Owner
Fulcrum Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,962,202
- Estimated value
- $13,114,889
- Report date
- 10 Nov 2021
- Price
- $3.31
- Ownership
- Indirect
Mark J. Levin - Director, 10%+ Owner at Fulcrum Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer ticker
- FULC on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Mark J. Levin since 16 Aug 2025
Reported holdings for Mark J. Levin in Fulcrum Therapeutics, Inc.
Form 4 holding
Director, 10%+ Owner
Fulcrum Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 75,800
- Estimated value
- $250,898
- Report date
- 10 Nov 2021
- Price
- $3.31
- Ownership
- Direct
Transaction history for Mark J. Levin in Fulcrum Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.